PERHA PHARMACEUTICALS
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.perha-pharma.fr
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phosphoproteomic Profile of Children With Down Syndrome
Completed
- Conditions
- Down Syndrome
- Interventions
- Biological: Blood sample
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Perha Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT06279208
- Locations
- 🇫🇷
CHRU de Brest, Brest, France
🇫🇷CHU Grenoble, Grenoble, France
🇫🇷Medilab, Parthenay, France
Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease
Phase 1
Recruiting
- Conditions
- Healthy VolunteersDown SyndromeAlzheimer's Disease
- Interventions
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Perha Pharmaceuticals
- Target Recruit Count
- 120
- Registration Number
- NCT06206824
- Locations
- 🇫🇷
Eurofins Optimed, Gières, France
News
No news found